BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30212614)

  • 1. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
    Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
    ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
    Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
    J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
    Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
    Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
    Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
    Front Immunol; 2021; 12():642383. PubMed ID: 34135888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro.
    Botros SS; William S; Beadle JR; Valiaeva N; Hostetler KY
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5284-7. PubMed ID: 19704122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
    Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
    Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
    Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
    Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
    Abdul-Ghani RA; Loutfy N; Hassan A
    Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
    da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
    SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.
    Peter Ventura AM; Haeberlein S; Konopka L; Obermann W; Grünweller A; Grevelding CG; Schlitzer M
    Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100259. PubMed ID: 34523746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
    Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarials in the treatment of schistosomiasis.
    Keiser J; Utzinger J
    Curr Pharm Des; 2012; 18(24):3531-8. PubMed ID: 22607145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.